Global skincare trends echo a major rise in acne and blemishes among people of all ages.
Blemishes are brought on by various factors, be it hormones, stress or other lifestyle factors. The stress brought on by the Covid-19 pandemic, along with the arrival of “maskne” has shown a significant increase in the demand for acne-related solutions and products.
Did you know that there is a lot more to blemishes than meets the eye? Visible blemishes (known as comedones) are usually our first priority, but for every visible blemish on the skin, there can be up to 100 microcomedones beneath the skin’s surface. These microcomedones can lead to future blemishes, which means that if you’re not addressing both the visible and invisible blemishes, your skin can get caught in a vicious cycle.
Specialist dermatologist, Dr Tarryn Jacobs, shares some helpful insights on the causes of acne-prone skin and essential tips on how to manage it. Watch the video below:
New: Anti-blemish Innovation
Eau Thermale Avène’s newest launch, Cleanance Comedomed, is designed to target both the visible and invisible stages of breakouts. It’s been clinically proven to reduce blemishes from seven days* and to limit the recurrence** of new ones with continued use. Cleanance Comedomed contains 25% Comedoclastin, a breakthrough, plant-based active ingredient that helps combat visible and invisible blemishes, as well as 67.5% Avène Thermal Spring Water, known for its soothing properties. This breakthrough product also has demonstrated efficacy on South African skin. Watch the video below to learn more:
Cleanance Comedomed is a non-greasy, fast-absorbing gel-cream that can be applied to the entire face twice a day. It’s suitable for skin prone to mild / moderate blemishes and can be used from the age of 12, making it a great option for teens too. Get yours from Dermastore, Clicks or Dis-Chem at R309.00.
This post was sponsored by Avène.
*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days.
** Comparative study conducted on 36 subjects (18-34 years) under dermatological control for 56 days. One group untreated (N=18), one group treated with Cleanance Comedomed (N=18), twice a day.